GlassScriptPhysician profile
Barry W Holcomb
NPI 1134107006
$506.43
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.90 · 2020: $33.62 · 2021: $78.09 · 2022: $229 · 2023: $53.85 · 2024: $71.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.02 | 2022-2024 | Ofev |
| Glaxosmithkline, LLC. | $51.58 | 2021-2022 | |
| United Therapeutics Corporation | $47.94 | 2022 | |
| Novartis Pharmaceuticals Corporation | $39.50 | 2022 | |
| Grifols USA, LLC | $36.01 | 2019-2022 | |
| Pulmonx Corporation | $33.62 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $29.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $28.65 | 2021-2022 | |
| Inspire Medical Systems, INC. | $27.25 | 2023 | Inspire |
| Philips North America LLC | $21.68 | 2022 | |
| Genzyme Corporation | $21.57 | 2024 | |
| Mylan Specialty L.P. | $20.62 | 2021 | |
| Itamar Medical INC | $16.95 | 2022 | |
| Sanofi Pasteur INC. | $15.98 | 2019 | |
| Eisai INC. | $15.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Holcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.